CRANBERRY TOWNSHIP, Pa.--(BUSINESS WIRE)--Aesynt™ , a leading provider of integrated pharmacy automation solutions for hospitals and health systems, today announced i.v.STATIONTM, an IV compounding robot, has been recognized in the 2014 IV Robots & Workflow Management Systems report from KLAS as the most likely choice among potential customers seeking to purchase an IV robot. Aesynt, which had the largest number of IV robot implementations and contracts during 2014, also led the market in quickest ROI, with 85 percent of customers realizing anticipated ROI in one to two years. The report attributed Aesynt’s competitive costs and smaller footprint as the primary drivers behind this.
Ranked against other IV compounding robots on the market, i.v.STATION received the highest results in the IV Robots Purchase Likelihood category, as it was considered 84 percent of the time by pharmacy directors and managers contemplating an IV robot purchase. Additionally, 27 percent of these respondents indicated they had already contracted with Aesynt or that i.v.STATION was their likely choice for a robot. Moreover, the report found i.v.STATION achieved the highest mindshare among participants from hospitals with 201-500 beds, with 81 percent of those respondents looking to purchase an IV robot.
“IV compounding is one of the highest risk areas of pharmacy practice and yet the typical hospital IV room is largely untouched by pharmacy automation. Financial challenges and patient safety risks, as evidenced in a recent USA Today article, are piquing provider interest in adopting in-house compounding solutions,” said Kraig McEwen, CEO of Aesynt. “As one of the first-movers in the IV automation space in the U.S., we’re thrilled to have been recognized by KLAS, as we feel it validates our growth and innovation over the past year as well as our commitment to helping our customers deliver safer, higher quality care, reduce costs and operate more efficiently.”
In addition to polling vendor preferences, KLAS found 80 percent of providers listed manual IV compounding as the area of the medication preparation process most vulnerable to medication errors.
“Pharmacy needs to continue to build a safer medication system for our patients and staff. Fortunately, technology is catching up with our needs in the IV room,” said David Webster, R.Ph., MSBA, Associate Director of Pharmacy Operations, University of Rochester Medical Center. “Solutions like Aesynt’s automated and semi-automated processes enhance workflow for compounding and dispensing of intravenous medications, offering a safe, efficient and cost-effective solution for the highest risk area of the pharmacy.”
The report comes months after Aesynt acquired Health Robotics, which signified its entrance into IV compounding and solidified its position as the only company in the market able to provide hospitals and health systems with an enterprise management solution for all medication forms. As one of the IV automation solutions in Aesynt’s robust suite, i.v.STATION enables pharmacists to more safely and efficiently produce ready-to-administer IVs, thereby helping hospitals and health systems to:
- Improve patient and clinician safety
- Eliminate life-threatening medication and diluent exchange errors
- Increase medication throughput
- Lower costs associated with IV compounding and dispensing
- Enhance medication potency
- Reduce errors, sterility risks and waste
- Comply with compounding and dispensing guidelines and regulations
KLAS’s IV Robots & Workflow Management Systems report gathers information around IV automation and workflow solutions through interviews with healthcare provider executives, managers, consultants and vendors. It benchmarks the performance of IV compounding technologies and provides an impartial assessment for vendors and providers to leverage for informed technology decision-making.
Aesynt’s full suite of automated and semi-automated solutions for sterile compounding will be featured at The 49th ASHP Midyear Clinical Meeting & Exhibition, Dec. 8-12 in Anaheim, California. For more information about Aesynt, visit www.aesynt.com.
KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and counted. Working with thousands of healthcare executives and clinicians, KLAS gathers data on software, services, medical equipment and infrastructure systems to deliver timely reports, trends and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving supplier performance. KLAS was founded in 1996, and their staff and advisory board average 25 years of healthcare.
Aesynt Incorporated is committed to continuously advancing medication delivery, offering integrated pharmacy automation solutions that help health systems to support improved patient outcomes, build stronger businesses and manage ongoing change. For more information, visit www.aesynt.com. Follow Aesynt on Twitter at https://twitter.com/aesynt.